The biopharma plastics market is projected to grow from USD 6.7 billion in 2025 to USD 19.8 billion by 2035, at a CAGR of 11.4%. Polyethylene – PE will dominate with a 48.6% market share, while protective wear will lead the application segment with a 42.3% share.